Supplementary Materials & Methods

Subcutaneous injection of Adenovirus in vivo
For each injection 40ul of 1×10 8 iu/ul adenovirus were injected subcutaneously.
Adenovirus expression was confirmed as described in our previous studies (Lei et al., Figure 6e and 8c in the present study. In some instances, BrdU (Sigma-Aldrich, St. Louis, USA) was injected abdominally 4h before sample collection.
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RT-PCR
RNA isolation, cDNA synthesis and PCR were performed using TRIZOL reagent (Invitrogen, Carlsbad, USA), ReverTra Ace-α (TOYOBO, Osaka, Japan) and 2×PCR mix (TIANGEN Biotech, Beijing, China), respectively. Primers are summarized in supplementary Table 1 .
SDS-PAGE and Western blotting
Western blot was peformed as previously described (Lei et al., 2012) . Secondary antibodies were HRP-labeled (1:10000; Beyotime, Nantong, China). GAPDH
(1:10000; Kang Chen Bio-tech, Shanghai, China) was used for normalization.
Wnt10b promoter reporter assay
Primers are used to clone DNA sequence: were used to acquire a 1336bp fragment. These fragments were cloned into a pGL3-Basic vector containing a luciferase reporter sequence to make pGL3/1.5k or pGL3/1.2k plasmids. RVprimer3 ， H2969-F2 and GLP2 are used to for PCR identification of positive transfections. pEGFP-Gsdma3 or pEGFP-N1 were co-transfected with pGL3/1.5k or pGL3/1.2k into JB6 cells. Luciferase reporter assay was used to detect Wnt10b promoter activity.
Cell culture and transfection
Mouse JB6 epidermal keratinocytes (ATCC) were cultured in DMEM (HyClone, Logan, USA) containing 10% FBS (Invitrogen, Carlsbad, USA) in 6-well plates.
Transient transfection of 4μg pEGFP-Gsdma3, pEGFP-N1, TOPflash/FOPflash, pGL3/1.2k or pGL3/1.5k plasmids was performed using LipofectamineTM 2000
(Invitrogen, Carlsbad, USA).
Statistical analysis
Data are reported as the mean ± SD (n = 3). Student's t test (Spss 13.0, SPSS Inc.) with P < 0.05 was accepted as significant. 
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